Spider venom molecule meets benchmarks to treat heart attack and stroke

A spider venom molecule being investigated by a University of Queensland team has met critical benchmarks towards becoming a treatment for heart attack and stroke.

Analysts highlight Masimo’s advantages over Apple, Fitbit ahead of proxy vote

Dive Brief: Analysts at Stifel have given a boost to Masimo ahead of a key shareholder vote, highlighting the potential for its W1 watch to

June 20, 2023

Power Secures $11.9M to Democratize Clinical Trials

What You Should Know: – Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round

February 22, 2024

Cause of Matthew Perry’s Tragic Passing Brings to Light the Stigma Still Tied to Ketamine and Other Psychedelics Being Used to Save Lives

Last Friday, the Los Angeles Medical Examiner’s Office released the autopsy report associated with Matthew Perry, star of the 90’s sitcom, “Friends,” and who was

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.